Advisor Group Holdings, Inc. Collegium Pharmaceutical, Inc Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 566 shares of COLL stock, worth $16,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
566
Previous 9,562 94.08%
Holding current value
$16,589
Previous $273,000 94.14%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$28.04 - $33.91 $252,247 - $305,054
-8,996 Reduced 94.08%
566 $16,000
Q4 2024

Feb 07, 2025
SELL
$28.61 - $41.86 $28 - $41
-1 Reduced 0.01%
9,562 $273,000
Q3 2024

Nov 13, 2024
SELL
$31.4 - $39.07 $4,584 - $5,704
-146 Reduced 1.5%
9,563 $369,000
Q2 2024

Aug 13, 2024
SELL
$31.36 - $39.99 $112,174 - $143,044
-3,577 Reduced 26.92%
9,709 $312,000
Q1 2024

May 10, 2024
BUY
$31.23 - $40.91 $388,345 - $508,715
12,435 Added 1461.22%
13,286 $515,000
Q4 2023

Feb 12, 2024
SELL
$21.16 - $30.8 $2,518 - $3,665
-119 Reduced 12.27%
851 $26,000
Q3 2023

Nov 13, 2023
BUY
$21.23 - $24.28 $1,974 - $2,258
93 Added 10.6%
970 $21,000
Q2 2023

Aug 10, 2023
SELL
$21.06 - $24.0 $186,886 - $212,976
-8,874 Reduced 91.01%
877 $18,000
Q1 2023

May 12, 2023
BUY
$23.0 - $29.88 $83,996 - $109,121
3,652 Added 59.88%
9,751 $233,000
Q4 2022

Feb 10, 2023
BUY
$16.14 - $23.55 $4,083 - $5,958
253 Added 4.33%
6,099 $141,000
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $77,841 - $101,203
5,035 Added 620.84%
5,846 $93,000
Q1 2022

May 04, 2022
SELL
$17.2 - $22.5 $3,921 - $5,130
-228 Reduced 21.94%
811 $16,000
Q3 2021

Nov 05, 2021
SELL
$17.75 - $25.39 $1,952 - $2,792
-110 Reduced 9.57%
1,039 $20,000
Q2 2021

Aug 02, 2021
BUY
$21.74 - $25.28 $1,673 - $1,946
77 Added 7.18%
1,149 $27,000
Q1 2021

May 13, 2021
SELL
$19.25 - $26.1 $9,028 - $12,240
-469 Reduced 30.43%
1,072 $25,000
Q4 2020

Feb 10, 2021
BUY
$17.83 - $22.29 $7,167 - $8,960
402 Added 35.29%
1,541 $30,000
Q3 2020

Nov 12, 2020
SELL
$15.78 - $20.82 $4,039 - $5,329
-256 Reduced 18.35%
1,139 $23,000
Q2 2020

Aug 14, 2020
BUY
$15.49 - $23.51 $11,044 - $16,762
713 Added 104.55%
1,395 $25,000
Q1 2020

May 18, 2020
BUY
$13.89 - $25.45 $9,472 - $17,356
682 New
682 $11,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
37.2M
Call Options Held
61.1K
Put Options Held
5.8K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email